Blockbuster diabetes obesity drug tirzepatide gets India launch nod
New Delhi: A top panel under the Central Drugs Standard Control Organisation (CDSCO) — India’s national regulatory body for pharmaceuticals and medical devices — has recommended regulatory approval to import …